
Rare Improvement of Survival in HR+ ERBB2- Advanced Breast Cancer
Author(s) -
Richard Simoneaux
Publication year - 2020
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000660236.74576.54
Subject(s) - palbociclib , fulvestrant , medicine , breast cancer , letrozole , metastatic breast cancer , oncology , cancer , aromatase inhibitor , anastrozole , tamoxifen , estrogen receptor